Clinical Trial: Plasmonic PhotoThermal Therapy (PPTT) With Glucose-Coated Gold Nanoparticles (TSK-001) in Patients With Nodular Basal Cell Carcinoma (nBCC)

U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891949) titled 'Plasmonic PhotoThermal Therapy (PPTT) With Glucose-Coated Gold Nanoparticles (TSK-001) in Patients With Nodular Basal Cell Carcinoma (nBCC)' on Oct. 08.

Brief Summary: Investigational Device

* TSK-001 injectable glucose-functionalised gold nanoparticle solution for intratumoural administration (0.3 mg nanoparticles in 1mL water for injection)

* Laser device 808 nm

Dose regimen TSK-001

* Part 1: Single intratumoural injection at 10%, 15%, and 20% of the tumour volume (vol/vol).

* Part 2: Two intratumoural injections at the maximum tolerated dose (MTD) or maximum administered dose (MAD) administered two weeks apart.

* Part 3: Tw...